Left ventricular dysfunction after two hours of polarizing or depolarizing cardioplegic arrest in a porcine model

Perfusion. 2019 Jan;34(1):67-75. doi: 10.1177/0267659118791357. Epub 2018 Jul 30.

Abstract

Introduction: This experimental study compares myocardial function after prolonged arrest by St. Thomas' Hospital polarizing cardioplegic solution (esmolol, adenosine, Mg2+) with depolarizing (hyperkalaemic) St. Thomas' Hospital No 2, both administered as cold oxygenated blood cardioplegia.

Methods: Twenty anaesthetized pigs on tepid (34°C) cardiopulmonary bypass (CPB) were randomised to cardioplegic arrest for 120 min with antegrade, repeated, cold, oxygenated, polarizing (STH-POL) or depolarizing (STH-2) blood cardioplegia every 20 min. Cardiac function was evaluated at Baseline and 60, 150 and 240 min after weaning from CPB, using a pressure-conductance catheter and epicardial echocardiography. Regional tissue blood flow, cleaved caspase-3 activity and levels of malondialdehyde were evaluated in myocardial tissue samples.

Results: Preload recruitable stroke work (PRSW) was increased after polarizing compared to depolarizing cardioplegia 150 min after declamping (73.0±3.2 vs. 64.3±2.4 mmHg, p=0.047). Myocardial tissue blood flow rate was high in both groups compared to the Baseline levels and decreased significantly in the STH-POL group only, from 60 min to 150 min after declamping (p<0.005). Blood flow was significantly reduced in the STH-POL compared to the STH-2 group 240 min after declamping (p<0.05). Left ventricular mechanical efficiency, the ratio between total pressure-volume area and blood flow rate, gradually decreased after STH-2 cardioplegia and was significantly reduced compared to STH-POL cardioplegia after 150 and 240 min (p<0.05 for both).

Conclusion: Myocardial protection for two hours of polarizing cardioplegic arrest with STH-POL in oxygenated blood is non-inferior compared to STH-2 blood cardioplegia. STH-POL cardioplegia alleviates the mismatch between myocardial function and perfusion after weaning from CPB.

Keywords: adenosine; cardiac function; cardioplegic arrest; esmolol; potassium; ventricular dysfunction.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenosine / adverse effects
  • Adenosine / therapeutic use
  • Animals
  • Cardioplegic Solutions / adverse effects
  • Cardioplegic Solutions / therapeutic use*
  • Cardiopulmonary Bypass / adverse effects
  • Cardiopulmonary Bypass / methods*
  • Disease Models, Animal
  • Heart Arrest, Induced / adverse effects
  • Heart Arrest, Induced / methods*
  • Magnesium / adverse effects
  • Magnesium / therapeutic use
  • Potassium / adverse effects
  • Potassium / therapeutic use
  • Propanolamines / adverse effects
  • Propanolamines / therapeutic use
  • Swine
  • Ventricular Dysfunction, Left / etiology*
  • Ventricular Dysfunction, Left / physiopathology

Substances

  • Cardioplegic Solutions
  • Propanolamines
  • Magnesium
  • Adenosine
  • esmolol
  • Potassium